See the DrugPatentWatch profile for Amidate
What is “Amidate,” and what does “cost” refer to?
“Amidate” is a brand name for etomidate (an anesthetic drug). “Amidate cost” usually means one of these: the price per vial/ampule, the cash price without insurance, or the amount billed under a hospital/infusion setting.
Because drug pricing depends heavily on:
- country/region,
- package size (vial/ampule strength),
- whether you’re buying as a patient vs. a hospital procurement contract,
- and whether a dose is being administered as part of anesthesia services,
I can’t state a reliable number without those details.
What drives the price of Amidate (etomidate)?
The billed cost typically changes with:
- Procurement contracts: hospitals often pay less than retail pharmacies.
- Packaging: different vial sizes and concentrations cost differently.
- Supply and sourcing: changes in manufacturer supply can affect short-term prices.
- Delivery/administration setting: outpatient vs inpatient billing uses different pricing structures.
- Insurance coverage: patients may see a lower out-of-pocket price than the billed amount.
How can I find the Amidate cost for your situation?
To give you an exact figure, tell me:
1) Your country (or ZIP/postal code)
2) Are you asking for the price of the drug itself or the total cost of anesthesia services?
3) The vial size/strength you’re seeing on the label (if you have it)
4) Are you a patient trying to buy it, or are you pricing a hospital purchase?
If you share those, I can narrow the search to the most relevant pricing model and estimate the likely cost range.
What if you’re looking for a cheaper alternative?
If your goal is to lower anesthesia drug cost, the best comparison depends on why Amidate is being used (induction choice, hemodynamic needs, etc.). In practice, clinicians often compare etomidate with other induction agents used in anesthesia protocols, but the right substitute is medical-dependent.
If you say what setting this is for (e.g., emergency RSI vs induction in OR), I can point you to common comparable options to discuss with a clinician/pharmacy.
Sources (none provided).